Dermatol. praxi. 2016;10(4):193-196 | DOI: 10.36290/der.2016.043

Treatment of scalp psoriasis with clobetasol foam

MUDr. Jan Hugo, MUDr. Spyridon Gkalpakiotis, Ph.D, MBA
Dermatovenerologická klinika 3. LF UK a FNKV, Praha

Up to 80 % of patients with psoriasis may have scalp lesions. Infliction in this localisation has substantial impact on quality of life, not only because of visibility, but also because of unpleasant subjective symptoms and resistance to treatment. We demonstrate a case with severe scalp psoriasis, successefully treated with clobetasol proprionate foam.

Keywords: scalp psoriasis, local therapy, clobetasol propionate

Published: December 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hugo J, Gkalpakiotis S. Treatment of scalp psoriasis with clobetasol foam. Dermatol. praxi. 2016;10(4):193-196. doi: 10.36290/der.2016.043.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Prussick R, Unnebrink K, Valdecantos WC. Efficacy of Adalimumab Compared With Methotrexate or Placebo Stratified by Baseline BMI in a Randomized Placebo-Controlled Trial in Patients With Psoriasis. J Drugs Dermatol. 2015; 14(8): 864-868. Go to PubMed...
    2. Mehta NN, Azfar RS, Shin DB, Neimann AL, Troxel AB, Gelfand JM. Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. Eur Heart J. 2010; 31(8): 1000-1006. Go to original source... Go to PubMed...
    3. Robati RM, Partovi-Kia M, Haghighatkhah HR, Younespour S, Abdollahimajd F. Increased serum leptin and resistin levels and increased carotid intima-media wall thickness in patients with psoriasis: is psoriasis associated with atherosclerosis? J Am Acad Dermatol. 2014; 71(4): 642-648. Go to original source... Go to PubMed...
    4. Davidovici BB, Sattar N, Prinz J, Puig L, Emery P, Barker JN, van de Kerkhof P, St?hle M, Nestle FO, Girolomoni G, Krueger JG. Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions. J Invest Dermatol. 2010; 130(7): 1785-1796. Go to original source... Go to PubMed...
    5. Scarpa R, Manguso F, D'Arienzo A, D'Armiento FP, Astarita C, Mazzacca G, Ayala F. Microscopic inflammatory changes in colon of patients with both active psoriasis and psoriatic arthritis without bowel symptoms. J Rheumatol. 2000; 27(5): 1241-1246. Go to PubMed...
    6. Christophers E. Psoriasis - epidemiology and clinical spectrum. Clin Exp Dermatol. 2001; 26(4): 314-320. Go to original source... Go to PubMed...
    7. Tichý M, Ditrichová D. Psoriáza kštice a aktuální léčebné možnosti. Dermatol. praxi 2010; 4(3): 131-134.
    8. Puig L, Strohal R, Husni ME, Tsai TF, Noppakun N, Szumski A, Yang S, Robertson D, Boggs R, Koenig AS. Cardiometabolic profile, clinical features, quality of life and treatment outcomes in patients with moderate-to-severe psoriasis and psoriatic arthritis. J Dermatolog Treat. 2015; 26(1): 7-15. Go to original source... Go to PubMed...
    9. Kim TW, Shim WH, Kim JM, Mun JH, Song M, Kim HS, Ko HC, Kim MB, Kim BS. Clinical characteristics of pruritus in patients with scalp psoriasis and their relation with intraepidermal nerve fiber density. Ann Dermatol. 2014; 26(6): 727-732. Go to original source... Go to PubMed...
    10. Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, Gottlieb A, Koo JY, Lebwohl M, Lim HW, Van Voorhees AS, Beutner KR, Bhushan R; American Academy of Dermatology. Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies.J Am Acad Dermatol. 2009; 60(4): 643-659. Go to original source... Go to PubMed...
    11. Work Group: Alan Menter, MD, Chair, Alice Gottlieb, MD, PhD, Steven R. Feldman, MD, PhD, Abby S. Van Voorhees, MD, Craig L. Leonardi, MD, Kenneth B. Gordon, MD, Mark Lebwohl, MD, John Y. M. Koo, MD, Craig A. Elmets, MD, Neil J. Korman, MD, PhD, Karl R. Beutner, MD, PhD, and Reva Bhushan, PhD. Guidelines of care for the management of psoriasis and psoriatic arthritis. J Am Acad Dermatol 2008; 58.
    12. Guo C, Yang Z, Li W, Zhu P, Myatt L, Sun K. Paradox of glucocorticoid-induced cytosolic phospholipase A2 group IVA messenger RNA expression involves glucocorticoid receptor binding to the promoter in human amnion fibroblasts. Biol Reprod. 2008; 78(1): 193-197. Go to original source... Go to PubMed...
    13. Albrecht L, Bourcier M, Ashkenas J Papp K. Topical psoriasis therapy in the age of biologics: Evidence based treatment recommendations. J Cut Med Surg, 2012. Go to original source...
    14. Koo JY. New developments in topical sequential therapy for psoriasis. Skin Therapy Lett. 2005; 10(9): 1-4. Go to original source...

    Return to the content


    Dermatology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.